ROYCE & ASSOCIATES LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$761,643
+65.4%
12,711
+99.0%
0.01%
+100.0%
Q2 2023$460,431
+879.6%
6,386
+1319.1%
0.00%
Q4 2019$47,000
-19.0%
450
-22.1%
0.00%
-100.0%
Q3 2019$58,000
+56.8%
578
+80.6%
0.00%
Q2 2019$37,000
-2.6%
320
+6.7%
0.00%
Q1 2019$38,000
-97.7%
300
-97.5%
0.00%
-100.0%
Q4 2018$1,628,000
+16180.0%
12,000
+17042.9%
0.02%
Q4 2017$10,000
+25.0%
70
+12.9%
0.00%
Q3 2017$8,000620.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders